Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

27.49 +0.31 (+1.14%)
Streaming Delayed Price Updated: 9:40 AM EDT, May 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,803,818
Open 27.21
Bid (Size) 27.48 (11)
Ask (Size) 27.49 (3)
Prev. Close 27.18
Today's Range 27.12 - 27.63
52wk Range 25.20 - 40.37
Shares Outstanding 5,606,688,356
Dividend Yield 5.97%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Contrarian Stocks That Could Make You a Fortune (If You Dare)
Sometimes the best way to invest your money is in the companies no one is bullish about, just like these three contrarian stocks to buy. 
Via InvestorPlace
Moderna Puts Up Big Quarterly Beat; Could Shares Notch A Breakout?
Moderna is forming its first base in over a year. Could shares top a buy point on the company's sales beat? 
Via Investor's Business Daily

Performance

YTD
-7.53%
-7.53%
1 Month
-0.83%
-0.83%
3 Month
+1.51%
+1.51%
6 Month
-9.90%
-9.90%
1 Year
-29.62%
-29.62%

More News

Read More
My Top 5 Favorite High-Yield Dividend Stocks to Buy in May
Via The Motley Fool
Pfizer's Stock Is a Buy. Here Are Six Reasons Why.
Via The Motley Fool
Thoughts For Thursday: Lingering Inflation
Via Talk Markets
Topics Economy
Exposures Interest Rates
Investor Optimism Improves Slightly Following Fed Decision
Via Benzinga
Topics Economy
Exposures Interest Rates
(PFE) - Analyzing Pfizer's Short Interest
Via Benzinga
Carvana, Enovix, Pfizer, Nio, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Via Benzinga
Topics Stocks
Exposures US Equities
Pfizer (PFE) Q1 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Why Pfizer Stock Blasted More Than 6% Higher Today
Via The Motley Fool
Dow Jumps 200 Points Following Fed Decision; Pfizer Earnings Top Estimates
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
PFE Stock Earnings: Pfizer Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
US Stocks Mixed Ahead Of Fed Meeting, Chipmakers Tumble After AMD Earnings, Bitcoin Sinks: What's Driving Markets Wednesday?
Via Benzinga
Topics Economy
Exposures Interest Rates
Pfizer Q1 Earnings and Revenues Beat Estimates
Via Talk Markets
Pfizer Embraces Direct-To-Consumer Model For Covid Antiviral, Says Comirnaty Revenues Continue To Perform Consistently With Expectations
Via Benzinga
Exposures COVID-19
GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook
Via Benzinga
Pfizer Jumps After Raising Its Outlook On The Heels Of A Big Quarterly Beat
Via Investor's Business Daily
Pfizer Reports First-Quarter 2024 Results
From Pfizer Inc.
Via Business Wire
Investor Sentiment Falls, Dow Snaps Five-Month Win Streak
Via Benzinga
Topics Stocks
Exposures US Equities
Amazon, Pfizer And 3 Stocks To Watch Heading Into Wednesday
Via Benzinga
Wall Street Set To Open Lower After AMD Earnings Disappoint As Traders Look To Fed's Powell For Relief: Why This Analyst Sees Incoming Summer Rally
Via Benzinga
Topics Economy
Exposures Interest Rates
7 Safe Haven Stocks That Can Withstand the Market’s Worst Meltdowns
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Pfizer Sees Less Revenue From Covid-19 Treatments, Stock Faces Headwinds Ahead Of Q1 Earnings
Via Benzinga
Exposures COVID-19
5 Top Stocks to Buy in May
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.